The book, “Nucleic Acids: A Natural Target for Newly Designed Metal Chelate-Based Drugs,” tackles the evolving landscape of disease treatment, shedding light on the escalating costs and the growing resistance posed by disease-causing agents. While the pharmaceutical market has provided valuable solutions for patients, it has also brought with it the burden of potential side effects that can compromise the body’s immune system. Patients find themselves in need of ways to bolster their immunity while managing the financial strain of disease treatment. Therefore, a shift in the paradigm of drug design is imperative, one that seeks to create drug molecules that are not only cost-effective but also readily accessible.
Metal complexes offer a promising avenue for this paradigm shift. Metal ions are integral components of biological molecules and exhibit a remarkable ability to bind to specific targets without causing harm to healthy cells. In this book, we provide a comprehensive compilation of recent data, encompassing the structural elucidation of metal complexes through advanced techniques and their binding patterns with specific targets.
Key Highlights:
Emphasizes recent advancements and methodologies employed in the creation of novel metal-based molecules and their interactions with biomolecules, particularly nucleic acids.
Explores the challenges in the development of innovative metal-based drugs.
Examines the progress in optical techniques for characterizing metal-based drugs.
This book is a valuable resource for researchers and professionals in the field, offering insights into the potential of metal chelate-based drugs as a new frontier in disease treatment.
